Your browser doesn't support javascript.
loading
The Ventilatory Ratio as a Predictor of Successful Weaning from a Veno-Venous Extracorporeal Membrane Oxygenator.
Fischbach, Anna; Wiegand, Steffen B; Simons, Julia Alexandra; Ammon, Liselotte; Kopp, Rüdger; Soccoro Matos, Guillermo Ignacio; Baigorri, Julio Javier; Crowley, Jerome C; Bagchi, Aranya.
Afiliação
  • Fischbach A; Department of Anesthesiology, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
  • Wiegand SB; Department of Anesthesiology and Intensive Care Medicine, Hannover Medical School, 30625 Hannover, Germany.
  • Simons JA; Department of Anesthesiology, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
  • Ammon L; Department of Anesthesiology, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
  • Kopp R; Department of Operative Intensive Care Medicine, University Hospital RWTH Aachen, Pauwelsstraße 30, 52074 Aachen, Germany.
  • Soccoro Matos GI; Department of Anesthesiology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Baigorri JJ; Department of Anesthesiology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Crowley JC; Department of Anesthesiology, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Bagchi A; Department of Anesthesiology, Massachusetts General Hospital, Boston, MA 02114, USA.
J Clin Med ; 13(13)2024 Jun 27.
Article em En | MEDLINE | ID: mdl-38999326
ABSTRACT

Background:

Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a critical intervention for patients with severe lung failure, especially acute respiratory distress syndrome (ARDS). The weaning process from ECMO relies largely on expert opinion due to a lack of evidence-based guidelines. The ventilatory ratio (VR), which correlates with dead space and mortality in ARDS, is calculated as [minute ventilation (mL/min) x arterial pCO2 (mmHg)]/[predicted body weight × 100 × 37.5].

Objectives:

The aim of this study was to determine whether the VR alone can serve as a reliable predictor of safe or unsafe liberation from VV-ECMO in critically ill patients.

Methods:

A multicenter retrospective analysis was conducted, involving ARDS patients undergoing VV-ECMO weaning at Massachusetts General Hospital (January 2016 - December 2020) and at the University Hospital Aachen (January 2012-December 2021). Safe liberation was defined as no need for ECMO recannulation within 48 h after decannulation. Clinical parameters were obtained for both centers at the same time point 30 min after the start of the SGOT (sweep gas off trial).

Results:

Of the patients studied, 83.3% (70/84) were successfully weaned from VV-ECMO. The VR emerged as a significant predictor of unsafe liberation (OR per unit increase 0.38; CI 0.17-0.81; p = 0.01). Patients who could not be safely liberated had longer ICU and hospital stays, with a trend towards higher mortality (38% vs. 13%; p = 0.05).

Conclusions:

The VR may be a valuable predictor for safe liberation from VV-ECMO in ARDS patients, with higher VR values associated with an elevated risk of unsuccessful weaning and adverse clinical outcomes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article